Voyageur Pharmaceuticals, Upgrades Frances Creek Barite to 98% BaSO4 with First Stage Gravity SeparationVoyageur Pharmaceuticals, Upgrades Frances Creek Barite to 98% BaSO4 with First Stage Gravity Separation Darin2019-12-18T13:48:04-07:00December 18th, 2019|Read More
Change of Name to Voyageur Pharmaceuticals Ltd., Frontier and Stock House Retained for Marketing & IR, Shares for Debt Transaction, Extension of Warrants, Resignation of DirectorChange of Name to Voyageur Pharmaceuticals Ltd., Frontier and Stock House Retained for Marketing & IR, Shares for Debt Transaction, Extension of Warrants, Resignation of Director Darin2019-12-11T12:57:47-07:00December 11th, 2019|Read More
Voyageur Minerals’ Joint Venture Company, ImagingX Pharmaceuticals, Submits Third Barium Contrast Product to Health Canada for Registration Voyageur Minerals’ Joint Venture Company, ImagingX Pharmaceuticals, Submits Third Barium Contrast Product to Health Canada for Registration Darin2019-11-06T12:56:19-07:00November 6th, 2019|Read More
Voyageur AGM and Name Change Voyageur AGM November 12th Update brent_adm2019-10-10T14:48:13-06:00October 10th, 2019|Read More
Voyageur Minerals Ltd Joint Venture Company, ImagingX Pharmaceuticals, Submits Second Barium Contrast Product to Health Canada for RegistrationVoyageur Minerals Ltd Joint Venture Company, ImagingX Pharmaceuticals, Submits Second Barium Contrast Product to Health Canada for Registration Darin2019-10-04T13:44:03-06:00October 4th, 2019|Read More
Voyageur Minerals Appoints Pharmaceutical Expert to the Board of DirectorsVoyageur Minerals Appoints Pharmaceutical Expert to the Board of Directors brent_adm2019-08-12T10:40:42-06:00August 12th, 2019|Read More
